Updated:
Catalent
Catalent is a global CDMO providing contract development and manufacturing services to pharma, biotech and self-care companies.
Catalent
Catalent operates as a contract development and manufacturing organization (CDMO) serving pharmaceutical, biotech and self-care companies. The firm's headquarters are in Somerset, New Jersey, and it maintains a global network of facilities. Its wealth origin and founding year are not publicly disclosed. Catalent provides integrated CDMO services spanning oral dose, biologics, specialty and clinical supply, as well as self-care products including OTC, dietary supplements and personal care. The firm works with partners from early-stage design through commercial manufacturing, offering technologies such as softgel, inhalation, cell and gene therapy, and bioavailability enhancement. Its portfolio includes services for small molecule, injectable, and oral manufacturing, as well as clinical supply services. The firm operates across North America, Europe and Asia (per the firm's website). No specific portfolio companies or deals are publicly disclosed. The size of Catalent's team is not publicly reported. The firm has not disclosed a recent operational event in the last 24 months. Catalent's structural differentiator is its end-to-end CDMO model, covering the full development and manufacturing lifecycle for both pharma and self-care products. The firm positions itself with pharma-grade expertise and consumer insight, serving both regulated therapeutics and consumer health brands under one organization.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Somerset
Corporate office
Somerset, NJ, United States
Sector focus
Frequently asked questions
What services does Catalent offer?
Catalent provides integrated CDMO services including oral dose, biologics, specialty and clinical supply, as well as self-care products like OTC, dietary supplements and personal care. They offer technologies such as softgel, inhalation, cell and gene therapy, bioavailability enhancement, and small molecule injectable and oral manufacturing. Services span from early-stage design to commercial manufacturing (per Catalent website).
What industries does Catalent serve?
Catalent serves the pharmaceutical, biotech and self-care industries. Its pharma clients include innovators in biologics, gene therapy and small molecule drugs, while its self-care division partners with health and wellness brands for OTC, dietary supplement and personal care products (per Catalent website).
Where does Catalent operate geographically?
Catalent operates globally with a worldwide network of facilities. The firm's headquarters are in Somerset, New Jersey, and it has established operations in North America, Europe and Asia (per Catalent website).
Does Catalent disclose its ownership or wealth origin?
Catalent does not publicly disclose its ownership structure or wealth origin. The firm is a publicly traded company on the New York Stock Exchange under the ticker CTLT (as of its last known filings), and its control or founding family is not disclosed on its public profile.
How does Catalent differ from other CDMOs?
Catalent differentiates itself by offering end-to-end services for both pharmaceutical and self-care markets under one organization. It combines pharma-grade expertise with consumer product capabilities, covering regulated therapeutics and consumer health. The firm also highlights its advanced technologies in softgel, inhalation, and cell and gene therapy manufacturing (per Catalent website).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: